ACTRN12620001246976招募中未知
Monash Cognition Imaging Study (MCIS): Characterising Mild Cognitive Impairment using multimodal biomarkers
试验速览
- 阶段
- 未知
- 状态
- 招募中
- 入组人数
- 100
研究概览
简要总结
暂无简介。
研究设计
- 研究类型
- Interventional
- 分配方式
- Non-randomised trial
- 主要目的
- Diagnosis
- 盲法
- Open (masking not used)
入排标准
- 年龄范围
- 30 Years 至 85 Years（—）
- 性别
- All
入选标准
- •1.Age 30-85 years
- •2.At least 6 years of education
- •3.Adequate English, visual & auditory acuity to complete cognitive testing
- •4.Reliable study partner
- •5.Subjective and objective cognitive impairment consistent with MCI
- •6.Potentially interested in participation in therapeutic drug trials
排除标准
- •1.Lifetime history of schizophrenia, schizoaffective disorder, or bipolar disorder.
- •2.Current major depressive episode or a past history of major depressive disorder with a high risk of relapse in the opinion of the investigator
- •3.Current drug or alcohol abuse/dependence.
- •4.History of alcohol abuse/dependence within 2 years of the onset of the symptoms of cognitive impairment.
- •5.Participants with a history of cancer (other than skin or in situ prostate cancer) within the previous 5 years.
- •6.Any significant disease or unstable medical condition that could affect cognitive testing or longevity (i.e., chronic renal failure, chronic hepatic disease, severe pulmonary disease).
- •7.Other neurological illness, including clinically significant stroke or Parkinson’s disease. A history of stable epilepsy is not an exclusion criterion.
- •8.Participants in whom magnetic resonance imaging (MRI) is contraindicated.
研究者
相似试验
已完成
不适用
A cognitive neuroimaging study using MRI: establishment of a measurement protocol for healthy controlshealthy controlJPRN-UMIN000031226Dokkyo Medical University, Center for Research Collaboration and Support83
进行中（未招募）
Unknown
nderstanding the effect of mepolizumab treatment on brain imaging and wellbeing in patients with severe asthmaRespiratoryAsthmaISRCTN74240789orth Bristol NHS Trust150
进行中（未招募）
不适用
CogniMS: observational study to assess cognition in patients with early Multiple Sclerosis - CogniMSObservational Study to assess cognition in patients with early Multiple Sclerosis.Relapsing-Remitting MS-patients diagnosed within 2 years and who have started the Betaferon treatment (interferon-beta-1b) during the last 6 monthsEUCTR2005-005989-37-FISchering Oy2,000
招募中
不适用
(f)MRI parameters and the relation with cognitive and emotional dysfunction in patients after treatment for M. Cushing and a comparison with patients with anxiety and depressioCushing's diseasehypercortisolism10021112NL-OMON36638eids Universitair Medisch Centrum50
招募中
不适用
MRI study to elucidate the mechanism of cognitive dysfunctioHealthy subjects, mild cognitive impairmentJPRN-UMIN000039675Keio University80